Fingerprint
Dive into the research topics of 'U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis
Andrea Meyerhoff
Research output: Contribution to journal › Article › peer-review
204
Scopus
citations